Cancer initiation and progression are orchestrated through local and systemic interactions between tumour and tumour-associated cells. A more detailed characterisation of these interactions has so far contributed to a new generation of antitumour strategies and to improved cancer prognosis. However, although we have gained increasing knowledge about the cellular and molecular constituents of tumour-promoting and tumour-suppressing microenvironments, an accurate map delineating the role of each of these constituents remains unavailable. By bringing together experts who have greatly contributed to our understanding of the tumour microenvironment, the Champalimaud Research Symposium 2022 (#CRSy22) will provide access to the most recent developments in basic and clinical research in this complex area. CRSy22 will take the form of a single-track scientific meeting with 18 invited speakers, talks selected from abstracts and 2 poster sessions, among other networking and social activities. The hybrid format will give delegates the option to attend and present their work either in-person or online.
Topics: Tumour Microenvironment, Cancer Research, Cancer Initiation, Metabolism, Cancer Progression, Metastasis, Therapy, Cancer Immunity